Anton H. van den Meiracker

11.9k total citations · 1 hit paper
218 papers, 7.9k citations indexed

About

Anton H. van den Meiracker is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anton H. van den Meiracker has authored 218 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Cardiology and Cardiovascular Medicine, 45 papers in Surgery and 42 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anton H. van den Meiracker's work include Blood Pressure and Hypertension Studies (60 papers), Heart Rate Variability and Autonomic Control (42 papers) and Hormonal Regulation and Hypertension (37 papers). Anton H. van den Meiracker is often cited by papers focused on Blood Pressure and Hypertension Studies (60 papers), Heart Rate Variability and Autonomic Control (42 papers) and Hormonal Regulation and Hypertension (37 papers). Anton H. van den Meiracker collaborates with scholars based in Netherlands, United States and United Kingdom. Anton H. van den Meiracker's co-authors include A.H. Jan Danser, Frans Boomsma, Joep H.M. van Esch, Maarten A.D.H. Schalekamp, Mariëtte H.W. Kappers, Anton J.M. Roks, Luuk te Riet, W. Edward Visser, Stefan Sleijfer and Langeza Saleh and has published in prestigious journals such as The Lancet, Circulation and Annals of Internal Medicine.

In The Last Decade

Anton H. van den Meiracker

215 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypertension

2015 529 citations Luuk te Riet, Joep H.M. van Esch et al. Circulation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anton H. van den Meiracker Netherlands	48	3.9k	1.6k	1.6k	1.5k	1.0k	218	7.9k
Jacqueline C.M. Witteman Netherlands	49	5.4k 1.4×	1.4k 0.8×	1.4k 0.9×	1.3k 0.9×	1.3k 1.2×	108	11.9k
Pamela Ouyang United States	60	5.7k 1.5×	2.0k 1.3×	2.5k 1.6×	704 0.5×	1.5k 1.4×	237	11.5k
Reinhold Kreutz Germany	48	5.7k 1.5×	1.3k 0.8×	2.6k 1.7×	1.8k 1.2×	1.6k 1.5×	398	11.0k
Andreas Festa United States	40	1.9k 0.5×	1.5k 0.9×	4.1k 2.6×	1.6k 1.1×	1.8k 1.8×	72	8.9k
Jane F. Reckelhoff United States	50	3.0k 0.8×	561 0.3×	3.2k 2.0×	1.2k 0.8×	1.6k 1.6×	143	8.7k
Branko Braam Canada	43	2.2k 0.6×	646 0.4×	895 0.6×	1.7k 1.1×	1.1k 1.1×	158	5.8k
James M. Ritter United Kingdom	43	3.3k 0.8×	1.0k 0.6×	816 0.5×	1.1k 0.7×	1.5k 1.4×	121	6.5k
Paul Smits Netherlands	48	2.7k 0.7×	1.2k 0.7×	1.1k 0.7×	1.3k 0.8×	1.3k 1.3×	215	6.9k
Paolo Ferrari Italy	52	2.4k 0.6×	1.7k 1.0×	3.1k 2.0×	3.1k 2.1×	1.0k 1.0×	342	9.8k
Francesco Perticone Italy	52	4.5k 1.1×	1.3k 0.8×	2.9k 1.8×	2.0k 1.3×	1.9k 1.8×	269	10.4k

Countries citing papers authored by Anton H. van den Meiracker

Since Specialization

Citations

This map shows the geographic impact of Anton H. van den Meiracker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton H. van den Meiracker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton H. van den Meiracker more than expected).

Fields of papers citing papers by Anton H. van den Meiracker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton H. van den Meiracker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton H. van den Meiracker. The network helps show where Anton H. van den Meiracker may publish in the future.

Co-authorship network of co-authors of Anton H. van den Meiracker

This figure shows the co-authorship network connecting the top 25 collaborators of Anton H. van den Meiracker. A scholar is included among the top collaborators of Anton H. van den Meiracker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton H. van den Meiracker. Anton H. van den Meiracker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saleh, Langeza, Michelle Broekhuizen, Daan Nieboer, et al.. (2022). Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1). Hypertension. 79(6). 1297–1307. 12 indexed citations

Rubio‐Beltrán, Eloísa, Catharina C. M. Schuiling‐Veninga, Birgit C. P. Koch, et al.. (2022). Trigeminovascular effects of propranolol in men and women, role for sex steroids. Annals of Clinical and Translational Neurology. 9(9). 1405–1416. 7 indexed citations

Nieboer, Daan, Langeza Saleh, Koen Verdonk, et al.. (2020). Angiogenic markers during preeclampsia: Are they associated with hypertension 1 year postpartum?. Pregnancy Hypertension. 23. 116–122. 8 indexed citations

Rossi, Gian Paolo, Teresa Maria Seccia, Matthias Barton, et al.. (2017). Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I. Journal of Hypertension. 36(3). 451–461. 28 indexed citations

Alsma, Jelmer, Anniek Brink, Soma Bahmany, et al.. (2017). [PP.05.12] DRUG NON-ADHERENCE AS MAJOR CAUSE OF SEVERE HYPERTENSION AT THE EMERGENCY DEPARTMENT. Journal of Hypertension. 35(Supplement 2). e123–e123.

Hesselink, Dennis A., et al.. (2017). Chlorthalidone Versus Amlodipine for Hypertension in Kidney Transplant Recipients Treated With Tacrolimus: A Randomized Crossover Trial. American Journal of Kidney Diseases. 69(6). 796–804. 36 indexed citations

Dijk, Suzanne C. van, Anke W. Enneman, Karin M. A. Swart, et al.. (2015). Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial. Journal of Hypertension. 33(9). 1897–1906. 31 indexed citations

Riet, Luuk te, Joep H.M. van Esch, Anton J.M. Roks, Anton H. van den Meiracker, & A.H. Jan Danser. (2015). Hypertension. Circulation Research. 116(6). 960–975. 529 indexed citations breakdown →

Lankhorst, Stephanie, Hans J. Baelde, Marian C. Clahsen‐van Groningen, et al.. (2015). Effect of high salt diet on blood pressure and renal damage during vascular endothelial growth factor inhibition with sunitinib. Nephrology Dialysis Transplantation. 31(6). 914–921. 21 indexed citations

10.

Mirza, Saira Saeed, Renée F.A.G. de Bruijn, Peter J. Koudstaal, et al.. (2015). The N-terminal pro B-type natriuretic peptide, and risk of dementia and cognitive decline: a 10-year follow-up study in the general population. Journal of Neurology Neurosurgery & Psychiatry. 87(4). 356–362. 43 indexed citations

11.

Danser, A.H. Jan & Anton H. van den Meiracker. (2015). New data do not SUPPORT triple RAAS blockade. Nature Reviews Nephrology. 11(5). 260–262. 13 indexed citations

12.

Kavousi, Maryam, Suzette Elias‐Smale, Joost H.W. Rutten, et al.. (2012). Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification. Annals of Internal Medicine. 9 indexed citations

13.

Kavousi, Maryam, Suzette Elias‐Smale, Joost H.W. Rutten, et al.. (2010). Comparison of Novel Markers in Prediction of Coronary Heart Disease Risk: the Rotterdam Study. Circulation. 122(21). 1 indexed citations

14.

Feelders, Richard A., Theo H.N. Groenland, Anton H. van den Meiracker, et al.. (2009). Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 95(2). 678–685. 171 indexed citations

15.

Jansen, Pieter M., Frans Boomsma, & Anton H. van den Meiracker. (2008). Aldosterone-to-renin ratio as a screening test for primary aldosteronism--the Dutch ARRAT Study.. PubMed. 66(5). 220–8. 38 indexed citations

16.

Tulen, J.H.M., et al.. (2000). Assessment of body position to quantify its effect on nocturnal blood pressure under ambulatory conditions. Journal of Hypertension. 18(12). 1737–1743. 14 indexed citations

17.

Bos, Willem Jan W., et al.. (1995). Hemodynamic consequences of Cimino fistulas studied with finger pressure measurements during fistula compression. Kidney International. 48(5). 1641–1645. 14 indexed citations

18.

Schalekamp, Maarten A.D.H., F. H. M. Derkx, & Anton H. van den Meiracker. (1992). Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists. Journal of Hypertension. 10(Sup 7). S157???164–S157???164. 14 indexed citations

19.

Meiracker, Anton H. van den, P J Admiraal, F. H. M. Derkx, et al.. (1990). Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.. BMJ. 301(6745). 205–210. 46 indexed citations

20.

Veld, A. J. Man inʼt, Anton H. van den Meiracker, & Maarten A.D.H. Schalekamp. (1988). Do Beta-blockers Really Increase Peripheral Vascular Resistance?. American Journal of Hypertension. 1(1). 91–96. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact